Elizabeth Gourd. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Antiemetics/adverse effectsAntiemetics/therapeutic useAntineoplastic Combined Chemotherapy Protocols/adverse effectsCisplatin/adverse effectsClinical Trials, Phase III as TopicCyclophosphamide/adverse effectsDexamethasone/therapeutic useDoxorubicin/adverse effectsEpirubicin/adverse effectsHumansIsoquinolines/therapeutic usePalonosetronQuality of LifeQuinuclidines/therapeutic useRandomized Controlled Trials as TopicThalidomide/adverse effectsThalidomide/therapeutic useTreatment OutcomeVomiting/chemically inducedVomiting/prevention & controlVomiting/psychology
Substances： See more » AntiemeticsIsoquinolinesQuinuclidinesEpirubicinThalidomidePalonosetronDexamethasoneDoxorubicinCyclophosphamideCisplatin
Year: 2017 PMID： 28890296 DOI： 10.1016/S1470-2045(17)30676-9
Source DB: PubMed Journal: Lancet Oncol ISSN： 1470-2045 Impact factor: 41.316